SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Gain (Loss) on Extinguishment of Debt
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) reported Gain (Loss) on Extinguishment of Debt of $755.12 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-09-24.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2026-09-24
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. gain (loss) on extinguishment of debt for the quarter ending 2026-06-30 was $755.12K.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. gain (loss) on extinguishment of debt for the quarter ending 2022-12-31 was -$2.12M.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. gain (loss) on extinguishment of debt for the quarter ending 2022-09-30 was $328.69K, a 425.90% increase year-over-year.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. gain (loss) on extinguishment of debt for the quarter ending 2021-09-30 was $62.50K.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. gain (loss) on extinguishment of debt for fiscal 2025 was $342.65K.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. gain (loss) on extinguishment of debt for fiscal 2022 was -$1.80M.
| Period end | Gain (Loss) on Extinguishment of Debt | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 9 month as first filed | Gain (Loss) on Extinguishment of Debt 12 month | Gain (Loss) on Extinguishment of Debt 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $755.12K 10-Q · filed 2026-09-24 | $755.12K 10-Q · filed 2026-09-24 | |||||
| 2025-12-31 | $342.65K 10-K · filed 2026-03-31 | ||||||
| 2022-12-31 | -$2.12M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-09-04 | -$1.80M derived: sum of 2 quarters · filed 2024-09-04 | -$1.80M 10-K/A · filed 2024-09-04 | $328.69K 10-K · filed 2023-03-15 | |||
| 2022-09-30 | $1.53M 10-K/A · filed 2024-09-04 | $328.69K 10-Q · filed 2023-11-13 | $328.69K 10-Q · filed 2023-11-13 | $73.01K 10-Q · filed 2022-11-14 | |||
| 2021-09-30 | $62.50K 10-Q · filed 2022-11-14 | $62.50K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |